News | News By Subject | News by Disease News By Date | Search News


Get Our FREE
Industry eNewsletter
Top Breaking News
A Look at the Deaths That Plagued Juno (JUNO) and Kite Pharma (KITE)'s CAR-T Trials     6/27/2017
FDA Calls Cara Therapeutics (CARA)' Kidney Disease Drug a Breakthrough, Stock Soars     6/23/2017
Amgen (AMGN) Goes on the Defensive When Critics Call Its Pipeline a Dud     6/23/2017
New Data Reveals This New York Biotech's Pipeline Could be a Game Changer     6/19/2017
Why Drug Giants Like Merck & Co. (MRK) and AstraZeneca PLC (AZN) Scientists are Looking in the Toilet for New Cancer Treatments     6/16/2017
Epizyme (EPZM) Falls as Investors Take in Disappointing Phase II Data     6/16/2017
SoCal's Regulus (RGLS) Sinks After AstraZeneca PLC (AZN) Bails on Lead NASH Drug     6/13/2017
Sanofi (SNY)'s Rumored Buyout Target Flexion (FLXN) Shows Off Mid-Stage Osteoarthritis Data     6/12/2017
Loxo Oncology (LOXO) Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It     6/8/2017
Tiny Bay Area Biotech Wants to Rattle the Billion-Dollar Injectable Drug Markets With a Single Pill     6/8/2017
Bristol-Myers Squibb (BMY) Loses $4.3 Billion in Market Value After ASCO Update     6/8/2017
Novartis AG (NVS) Lays Out R&D Game Plan at Meet and Greet With 30 Execs in Boston     6/2/2017
A Look at Gilead (GILD)'s Possible New Drug Strategy     6/1/2017
BioPharm Executive: Here's What to Look For at ASCO     5/31/2017
How Much Juno (JUNO) Spent on Its Failed CAR-T Drug     5/30/2017

Featured Stories
Why This Small Biotech With A Single Drug In Human Trials Might Be A Big Winner     6/22/2017
Vanda (VNDA): Several Catalysts Coming Up     6/21/2017
While Amgen (AMGN)-Size Biotechs Run Into Trouble, These Are The Biotechs With The Most Promising Pipelines     6/19/2017
How This Small Washington Biotech Stands To Outperform Rivals Amgen (AMGN), Eli Lilly (LLY) And Teva (TEVA) In Migraine Drugs     6/9/2017
Why This Struggling Socal Biotech Could Be The Next Big Marijuana Stock     5/23/2017
Cara Therapeutics (CARA): A Look At The Next Catalyst—Osteoarthritis     5/16/2017
TG Therapeutics (TGTX): Significant Near-Term Catalysts For 2017     5/16/2017
4 Biotechs That Could Explode Or Crash In May     5/5/2017
A New Weapon In The War Against Opioid Abuse?     5/4/2017
Finally! Novartis AG (NVS) To Release Long-Awaited Juliet CAR-T Data In June     4/25/2017
Top 15 R&D Spenders In The World For 2017     4/24/2017
Can Psoriatic Arthritis Lift Gilead (GILD)'s Sinking Ship?     4/20/2017
Matinas BioPharma's Weak Drug Pipeline And Investors With Fraudulent Histories     3/27/2017
This Cheap Michigan Biotech Could Have Major Phase II Catalysts Coming     3/20/2017
Why Ionis Pharma (IONS)'s Extensive And Deep Pipeline Could Get Investors' Hearts Pumping     3/8/2017
Teva (TEVA) And Xenon Pharma Announce Phase II Study Of Topical TV-45070 In Patients With Post-Herpetic Neuralgia (PHN) Did Not Meet Primary Endpoint     6/27/2017
TrovaGene (TROV) Announces Submission Of Investigational New Drug Application To Initiate Phase Ib/II Clinical Trial Of PCM-075 For Acute Myeloid Leukemia     6/27/2017
TP Therapeutics Announces FDA Orphan Drug Designation Granted To TPX-0005 For Treatment Of Non-Small Cell Lung Adenocarcinomas Harboring ALK, ROS1, Or NTRK Oncogenic Rearrangements     6/27/2017
Ra Pharma (RARX) Announces Initial Data From Phase II Clinical Trial Of RA101495 In PNH     6/27/2017
Araclon Biotech Initiates Phase II Clinical Trials Of Its Alzheimer's Vaccine     6/27/2017
TapImmune (TPIV) Reaches 50% Patient Enrollment Benchmark In Phase II Study Of Novel T-Cell Vaccine Targeting Triple-Negative Breast Cancer     6/27/2017
Alnylam (ALNY) And Sanofi Genzyme (SNY) To Present New Clinical Trial Results At The International Society Of Thrombosis And Haemostasis (ISTH) Congress     6/27/2017
Matinas BioPharma (MTNB) Tanks As Lead Drug Fails To Match Standard-Of-Care Treatment In Phase II Infection Trial     6/26/2017
SoCal's Neothetics (NEOT) Craters As Fat-Reduction Drug Flunks Phase II Study     6/26/2017
European Hematology Association: Clinical And Biologic Covariates Of Outcomes In ZUMA-1: A Pivotal Trial Of Axicabtagene Ciloleucel (Axi-Cel; KTE-C19) In Patients With Refractory Aggressive Non-Hodgkin Lymphoma (NHL)     6/26/2017
European Hematology Association: Global Trial Of The Efficacy And Safety Of CTL019 In Adult Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma: An Interim Analysis Of The JULIET Study     6/26/2017
European Hematology Association: Multicenter Open-Label Phase 2 Study Of Ibrutinib In Chronic Graft Versus Host Disease (cGVHD) After Failure Of Corticosteroids     6/26/2017
NewVac Presented Results Of Quisinostat's Phase II Clinical Trial At ASCO 2017     6/26/2017
Semnur Announces Successful Phase I/II Trial In Patients With Radicular Pain For Its Lead Product, SP-102     6/26/2017
Verastem (VSTM) Reports Phase II Long-Term Follow-Up Data For Duvelisib In Patients With Double-Refractory Follicular Lymphoma And Small Lymphocytic Lymphoma At The 22nd Congress Of The European Hematology Association     6/26/2017

More News
No News Posted on that date

Career Tips
Genentech (RHHBY) Wins No. 1 Top Spot as The Ideal Employer in Life Sciences     6/23/2017
8 New Ways Scientists Can Get Their CV At The Top Of A Search     6/21/2017
Avoid Doing These 3 Things At Your Biotech Or Biopharma Jobs Interview     6/21/2017
10 Resume Rules Smart Job Seekers Break     6/21/2017
6 Must-Ask Questions Before Accepting The Job Offer     6/21/2017
11 Signs You Aced Your Interview     6/21/2017
16 Questions Top Pharma Applicants Should Ask During the Job Interview     6/9/2017
Top 10 Life Science Job Trends in 2017     6/9/2017
Smart Biotech Careers for Job Seekers With No PhD     6/9/2017
Top 3 Most Desirable Skills In The ‘New Breed’ Of Pharma Sales Rep     6/8/2017
5 Strategies For Getting Hired Into Life Science Positions     6/8/2017
5 Easy(ish) Steps To Building A Biopharma Career     6/8/2017
The Tiny Yet Powerful Cover Letter     6/8/2017
3 Job Interview Mistakes You Think You Avoided But Actually Didn’t     6/8/2017
How to Follow Up After a Career Event     6/5/2017

Other News Sources